Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06442293

Safety and Tolerability of 2 Dietary Supplement Beverages Designed to Maintain Healthy Blood Pressure.

An Evaluation of the Safety and Tolerability of 2 Dietary Supplement Beverages Designed to Maintain Normal Blood Pressure in Normal, Healthy Individuals.

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
18 (estimated)
Sponsor
USANA Health Sciences · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

This study is designed to evaluate the safety and tolerability of two distinct dietary supplement beverage formulations designed to maintain normal blood pressure. In this study, safety and tolerability will be assessed among otherwise healthy, normotensive individuals.

Detailed description

The objective of this study is to evaluate the safety of 2 dietary supplement beverage formulations in healthy, normotensive individuals. The study period will be 29 days in length, during which we will monitor and catalogue the blood pressure (BP), heart rate (HR), comprehensive metabolic panel (CMP), complete blood count (CBC), as well as self-reported side effects of all subjects on a daily basis. Note that each beverage will be evaluated at multiple doses: Beverage 1 will be monitored at a low, medium and high dose, where the medium and high dose is quantitatively twice (2X) and thrice (3X) the low dose (1X), respectively. Similarly, we will evaluate Beverage 2 at a low dose and high dose where the high dose is quantitatively twice (2X) of the low dose (1X). A placebo treatment will also be incorporated into this study as well. As such, there will be 6 groups in this study. Three subjects will be assigned to each treatment group for a total of 18 subjects.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTTreatment 1A dietary supplement containing beet root extract, arginine and citrulline
DIETARY_SUPPLEMENTTreatment 2A traditional Chinese medicine (TCM)-based dietary supplement containing chrysanthemum extract and eucommia bark extract
DIETARY_SUPPLEMENTPlaceboa placebo supplement that is similar in appearance to treatment 1

Timeline

Start date
2024-07-01
Primary completion
2024-08-15
Completion
2024-08-15
First posted
2024-06-04
Last updated
2024-06-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06442293. Inclusion in this directory is not an endorsement.